European Archives - Page 1042 of 1137 - European Medical Journal

EMJ

The origins of CDK by Tim Hunt

Tim Hunt, FRS, FMedSci describes the path that led him to identify cyclin-dependent kinases (CDK), along with colleagues Paul Nurse and Leland Hartwell…

EMJ

Chemoprevention in breast cancer

Jack Cuzick, PhD, FMedSci, FRCP(hon), of the Queen Mary University of London, UK gives an overview of the session ‘Prevention is better than cure’…

EMJ

Tumour: stroma interactions

In the session ” Tumour: stroma interactions” presented at the 2015 National Cancer Research Institute (NCRI) Cancer Conference, the importance of…

EMJ

European Medicines Agency Validates Gilead’s Marketing Application for Investigational Fixed-Dose Combination of Sofosbuvir/Velpatasvir for the Treatment of Hepatitis C

Foster City, Calif., December 4, 2015 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its Marketing Authorization Application (MAA) for…

EMJ

COPD Patients at Risk from Overuse of Inhaled Corticosteroids

DISCREPANCIES between guideline recommendations and the prescription of inhaled corticosteroids (ICS) in the UK suggest that these drugs may be…

EMJ

Animal Contact Reduces Risk of Paediatric Asthma

CHILDHOOD contact with dogs and farm animals reduces the risk of children developing asthma, according to new research from Sweden.

EMJ

Want the Opportunity to Design a Front Cover for EMJ?

Calling all creative people: photographers, painters, and potters alike. Are you an artist looking to create something engaging, something original…

EMJ

Should Type 2 Diabetes Management Be More of a Priority in Post-Acute Coronary Syndrome Patients?

A full recording of the Takeda-sponsored symposium held at the 51st Annual Meeting of the European Association for the Study of Diabetes in Stockholm…

EMJ

Subtyping Serotonergic Neurons

SEROTONERGIC neurons are brain cells that produce the neurotransmitter serotonin, which is involved in the regulation of an individual’s mood, appetite…

EMJ

The Achilles Heel of Neuroblastoma: A New Treatment Target

AN EXPERIMENTAL drug that has the ability to exploit the ‘Achilles heel’ of neuroblastoma has been identified by a team of Children’s Cancer Institute…